FellowshipIntensive summer program for machine learning scientists to create ventures.

Flagship Pioneering is a venture creation firm based in Cambridge, Massachusetts, focused on inventing and funding biotechnology companies. Founded in 2000, it emphasizes a hands-on approach to building companies from scientific research and technological advancements.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
Pages connected to the organization that it may not control.
Third-party rankings
| Ranking | Edition | Position | Since last edition | Trust | What it measures |
|---|---|---|---|---|---|
| Strebulaev-Jackson Venture Ranking: Top 50 Biotech VC Firms | 2026 | #9 | No prior edition | B | Performance |
Flagship Pioneering is a Cambridge, Massachusetts-based venture creation firm founded in 2000. The organization focuses on advancing healthcare through the creation and development of innovative biotechnology companies. Known for its unique approach, Flagship leverages scientific research and technological advancements to address significant health challenges. The firm operates by originating companies internally through its labs and business units, financing and building them through successive stages. Flagship has founded over 140 companies and manages substantial capital, including a recent $3.4 billion fund, with a mission to drive innovation through scientific creativity.
Flagship Pioneering invests primarily in the biotechnology sector, targeting early-stage companies that are developing groundbreaking therapies and technologies. The organization emphasizes a hands-on approach to company creation, often collaborating directly with scientists and entrepreneurs to nurture innovative ideas that can lead to significant advancements in healthcare.
Flagship Pioneering adds value to its portfolio companies through direct collaboration with scientists and entrepreneurs, providing hands-on support in the development of innovative therapies and technologies. The organization leverages its extensive network and expertise in biotechnology to help companies navigate challenges and accelerate their growth.
Flagship Pioneering primarily invests in early-stage biotechnology companies that are developing transformative therapies and technologies. The firm looks for companies that can generate multiple products from a single scientific hypothesis.
Founders interested in pitching to Flagship should prepare a detailed presentation that outlines their scientific hypotheses, potential market impact, and how their work aligns with Flagship's focus on biotechnology and healthcare.
Flagship Pioneering acts not only as an investor but also as an inventor and company builder. The firm emphasizes internal company origination and collaborates closely with scientists and entrepreneurs to develop innovative solutions.
Flagship Pioneering primarily focuses on North America but has expanded its operations into the UK and Asia-Pacific regions to support collaborations and scaling.
While specific check sizes are not disclosed, recent examples indicate that initial commitments can be substantial, such as the $50 million commitment for Serif Biomedicines.
Flagship Pioneering provides comprehensive support to its portfolio companies, including scientific expertise, strategic partnerships, and access to capital, ensuring that they have the resources needed to succeed.
From public sources
Flagship's official Noubar Afeyan biography dates its founding to 2000.
Source: Noubar Afeyan, Founder & CEOPitchBook's public Flagship Pioneering preview lists Expedition Medicines with deal date 2025-10-22.
Source: Flagship Pioneering investment portfolio | PitchBookPitchBook's public Flagship Pioneering preview lists Foghorn Therapeutics with deal date 2026-01-13.
Source: Flagship Pioneering investment portfolio | PitchBookPitchBook's public Flagship Pioneering preview lists Serif (Biotechnology) with deal date 2026-04-21.
Source: Flagship Pioneering investment portfolio | PitchBookPitchBook's public Flagship Pioneering preview lists Terion (Business/Productivity Software) with deal date 2026-06-01.
Source: Flagship Pioneering investment portfolio | PitchBookPitchBook's public Flagship Pioneering preview lists Iris Labs with deal date 2026-10-06.
Source: Flagship Pioneering investment portfolio | PitchBookSuperscout Pro
Is this page right?Reviewed · How the research works